Mounjaro To Lead Eli Lilly's Q3 Growth
30/10 05:49
Eli Lilly stock (NYSE: LLY) will report its Q3 results on Wednesday, October 30. The pharmaceutical giant is expected to garner $12.1 billion in sales and $1.45 in adjusted earnings per share, per the consensus estimates. All eyes will be on Eli Lilly’s diabetes drug &ndash...